@article{ART002898968},
author={Han Inhee},
title={Ortho-Cellular Nutrition Therapy (OCNT) Prescription for Patients with Bronchiectasis and End-stage Liver Cancer},
journal={CELLMED},
issn={3022-6805},
year={2022},
volume={12},
number={4},
pages={18-18},
doi={10.5667/CellMed.2022.018}
TY - JOUR
AU - Han Inhee
TI - Ortho-Cellular Nutrition Therapy (OCNT) Prescription for Patients with Bronchiectasis and End-stage Liver Cancer
JO - CELLMED
PY - 2022
VL - 12
IS - 4
PB - Cellmed Orthocellular Medicine and Pharmaceutical Association
SP - 18
EP - 18
SN - 3022-6805
AB - In Korea, liver cancer is the sixth most prevalent malignancy and the second leading cause of cancer-related mortality. The peak incidence of liver cancer deaths occurs between the ages of 40 and 59. (e.g. Yoon et al. 2021) The patient is a 69-year-old female with bronchiectasis as an underlying condition. She underwent left lower lobe resection for the disease, and in 2009 she was diagnosed with liver cancer and experienced a recurrence after a full recovery. In the case of such patients, the most effective OCNT prescription is recommended.
KW - Ortho-Cellular Nutrition Therapy;OCNT;End-stage Liver Cancer;Liver Cancer
DO - 10.5667/CellMed.2022.018
ER -
Han Inhee. (2022). Ortho-Cellular Nutrition Therapy (OCNT) Prescription for Patients with Bronchiectasis and End-stage Liver Cancer. CELLMED, 12(4), 18-18.
Han Inhee. 2022, "Ortho-Cellular Nutrition Therapy (OCNT) Prescription for Patients with Bronchiectasis and End-stage Liver Cancer", CELLMED, vol.12, no.4 pp.18-18. Available from: doi:10.5667/CellMed.2022.018
Han Inhee "Ortho-Cellular Nutrition Therapy (OCNT) Prescription for Patients with Bronchiectasis and End-stage Liver Cancer" CELLMED 12.4 pp.18-18 (2022) : 18.
Han Inhee. Ortho-Cellular Nutrition Therapy (OCNT) Prescription for Patients with Bronchiectasis and End-stage Liver Cancer. 2022; 12(4), 18-18. Available from: doi:10.5667/CellMed.2022.018
Han Inhee. "Ortho-Cellular Nutrition Therapy (OCNT) Prescription for Patients with Bronchiectasis and End-stage Liver Cancer" CELLMED 12, no.4 (2022) : 18-18.doi: 10.5667/CellMed.2022.018
Han Inhee. Ortho-Cellular Nutrition Therapy (OCNT) Prescription for Patients with Bronchiectasis and End-stage Liver Cancer. CELLMED, 12(4), 18-18. doi: 10.5667/CellMed.2022.018
Han Inhee. Ortho-Cellular Nutrition Therapy (OCNT) Prescription for Patients with Bronchiectasis and End-stage Liver Cancer. CELLMED. 2022; 12(4) 18-18. doi: 10.5667/CellMed.2022.018
Han Inhee. Ortho-Cellular Nutrition Therapy (OCNT) Prescription for Patients with Bronchiectasis and End-stage Liver Cancer. 2022; 12(4), 18-18. Available from: doi:10.5667/CellMed.2022.018
Han Inhee. "Ortho-Cellular Nutrition Therapy (OCNT) Prescription for Patients with Bronchiectasis and End-stage Liver Cancer" CELLMED 12, no.4 (2022) : 18-18.doi: 10.5667/CellMed.2022.018
